title: DHEA, a neurosteroid, decreases cocaine self-administration and reinstatement of cocaine-seeking behavior in rats.
abstract: Dehydroepiandrosterone (DHEA), which can act as a potential antidepressant in both animals and humans, appears to lower distress involved with cocaine withdrawal. In fact, a role for neurosteroids in modulation of substance-seeking behavior is becoming increasingly clear. Therefore, we tested the effects of DHEA on the self-administration of cocaine (1 mg/kg/infusion) by rats. At maintenance, a relatively low dose of exogenous DHEA (2 mg/kg; i.p.) attenuated cocaine self-administration after several days of chronic treatment. More than 2 weeks (19 days) of daily DHEA injections were required to decrease the cocaine-seeking behavior of rats to less than 20% of their maintenance levels. DHEA does not seem to decrease cocaine self-administration by increasing the reinforcing properties of the drug, as indicated by a cocaine dose-response determination. After being subjected to extinction conditions in the presence of DHEA, rats demonstrated a minimal response to acute exposure to cocaine (10 mg/kg), which indicated a protective effect of DHEA on relapse to cocaine usage. Our results suggest a potential role for the neurosteroid DHEA in controlling cocaine-seeking behavior, by reducing both the desire for cocaine usage and the incidence of relapse.
authors.affiliation: Faculty of Life Sciences and The Leslie and Susan Gonda (Goldschmied) Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan, Israel.
authors.forename: Ravid
authors.initials: R
authors.lastname: Doron
authors.forename: Lilach
authors.initials: L
authors.lastname: Fridman
authors.forename: Iris
authors.initials: I
authors.lastname: Gispan-Herman
authors.forename: Rachel
authors.initials: R
authors.lastname: Maayan
authors.forename: Abraham
authors.initials: A
authors.lastname: Weizman
authors.forename: Gal
authors.initials: G
authors.lastname: Yadid
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000704:Analysis of Variance; D000779:Anesthetics, Local / Q000008:administration & dosage*; D000818:Animals; D016739:Behavior, Addictive / Q000188:drug therapy* / Q000209:etiology; D001522:Behavior, Animal / Q000187:drug effects; D003042:Cocaine / Q000008:administration & dosage*; D019970:Cocaine-Related Disorders / Q000150:complications; D003216:Conditioning, Operant / Q000187:drug effects; D003687:Dehydroepiandrosterone / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012646:Self Administration; D013395:Sucrose / Q000008:administration & dosage
chemical_list: D000276:Adjuvants, Immunologic; D000779:Anesthetics, Local; D003687:Dehydroepiandrosterone; D013395:Sucrose; D003042:Cocaine